Pura Vida Investments’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-89,612
Closed -$1.25M 261
2021
Q4
$1.25M Buy
89,612
+6,346
+8% +$103K 0.05% 165
2021
Q3
$1.56M Sell
83,266
-16,596
-17% -$313K 0.05% 202
2021
Q2
$2.08M Sell
99,862
-24,378
-20% -$605K 0.06% 158
2021
Q1
$3.51M Buy
124,240
+48,440
+64% +$1.53M 0.1% 134
2020
Q4
$2.48M Sell
75,800
-26,266
-26% -$923K 0.09% 137
2020
Q3
$3.13M Buy
+102,066
New +$2.25M 0.16% 106
2018
Q1
Sell
-50,000
Closed -$765K 85
2017
Q4
$765K Buy
+50,000
New +$737K 0.32% 61

Other funds holding KURA

Pura Vida Investments's KURA Position: Q1 2022 in Review

Pura Vida Investments sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 89,612 shares — an estimated $1.25M sold.

Pura Vida Investments first reported a position in KURA in Q4 2017 and held it in 7 quarters. The position peaked at $3.51M in Q1 2021. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Pura Vida Investments reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 89,612 Kura Oncology shares in Q1 2022, an estimated $1.25M.
  • Pura Vida Investments first reported a position in Kura Oncology in Q4 2017 and held it in 7 quarters.
  • Pura Vida Investments's Kura Oncology position peaked at $3.51M in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.